Thomas D B
Environ Health Perspect. 1983 Apr;50:209-18. doi: 10.1289/ehp.8350209.
Epidemiologic and endocrinologic studies of breast cancer etiology are reviewed in the context of the Moolgavkar two-stage model for mammary carcinogenesis. Promoters are hypothesized to enhance the growth of stem and intermediate cells, and initiators are assumed to cause stem and intermediate cells to give rise to intermediate and tumor cells, respectively. Although all epidemiologic features of breast cancer can be explained in terms of the cellular events supposed by the model, the specific causes of breast cancer are largely unknown. Aberrations in endogenous steroid sex hormones most probably act as promoters, although their exact nature and etiology are unclear. Ionizing radiation is the only known initiator. The two-stage model implies that others exist and that they are responsible for both the international variation in risk of breast cancer, and its familial aggregation. Results of endocrinologic studies suggest either that aberrations in endogenous sex hormones serve as such initiators or are correlated with them, or that familial and international variations in risk are mediated by promoters.
在穆尔加夫卡尔乳腺致癌作用两阶段模型的背景下,对乳腺癌病因的流行病学和内分泌学研究进行了综述。据推测,促癌剂可促进干细胞和中间细胞的生长,而引发剂则被认为分别导致干细胞和中间细胞产生中间细胞和肿瘤细胞。尽管乳腺癌的所有流行病学特征都可以用该模型所假设的细胞事件来解释,但乳腺癌的具体病因在很大程度上仍不清楚。内源性甾体性激素的异常很可能起到促癌剂的作用,尽管其确切性质和病因尚不清楚。电离辐射是唯一已知的引发剂。两阶段模型意味着还存在其他引发剂,它们既导致了乳腺癌风险的国际差异,也导致了其家族聚集性。内分泌学研究结果表明,内源性性激素的异常要么作为此类引发剂起作用,要么与之相关,要么风险的家族和国际差异是由促癌剂介导的。